Nu Skin Enterprises, Inc. (NYSE:NUS) President Ryan S. Napierski sold 11,667 shares of the stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $63.84, for a total value of $744,821.28. Following the transaction, the president now directly owns 71,634 shares in the company, valued at approximately $4,573,114.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Nu Skin Enterprises, Inc. (NYSE NUS) traded down $2.75 during trading hours on Friday, reaching $60.86. The company’s stock had a trading volume of 943,231 shares, compared to its average volume of 458,565. The company has a market capitalization of $3,222.05, a PE ratio of 21.50 and a beta of 1.57.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting the consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The company had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. During the same period last year, the company posted $0.98 earnings per share. The firm’s revenue was down 6.7% compared to the same quarter last year. equities research analysts predict that Nu Skin Enterprises, Inc. will post 3.24 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.37%. The ex-dividend date of this dividend is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 52.75%.

TRADEMARK VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/11/03/ryan-s-napierski-sells-11667-shares-of-nu-skin-enterprises-inc-nus-stock.html.

A number of large investors have recently added to or reduced their stakes in the business. Prudential Financial Inc. raised its position in Nu Skin Enterprises by 826.4% in the third quarter. Prudential Financial Inc. now owns 374,549 shares of the company’s stock valued at $23,027,000 after purchasing an additional 334,120 shares during the period. American Century Companies Inc. raised its position in Nu Skin Enterprises by 12.0% in the third quarter. American Century Companies Inc. now owns 478,618 shares of the company’s stock valued at $29,425,000 after purchasing an additional 51,460 shares during the period. Old Mutual Global Investors UK Ltd. raised its position in Nu Skin Enterprises by 179,062.6% in the third quarter. Old Mutual Global Investors UK Ltd. now owns 503,447 shares of the company’s stock valued at $30,951,000 after purchasing an additional 503,166 shares during the period. New York State Teachers Retirement System raised its position in Nu Skin Enterprises by 33.6% in the third quarter. New York State Teachers Retirement System now owns 19,100 shares of the company’s stock valued at $1,174,000 after purchasing an additional 4,800 shares during the period. Finally, Crossmark Global Holdings Inc. purchased a new position in Nu Skin Enterprises in the third quarter valued at about $334,000. 79.74% of the stock is currently owned by institutional investors.

Several research analysts recently weighed in on the company. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. BidaskClub lowered Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation increased their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a research report on Monday, July 10th. Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the stock a “sell” rating in a research report on Thursday, August 3rd. Finally, TheStreet raised Nu Skin Enterprises from a “c+” rating to a “b” rating in a research report on Wednesday, August 2nd. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $62.00.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.